Home
Name
ABX-IL-8
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--monoclonal antibody
NSC Number
None
Primary Site
Skin cancer
Histology
None
Remarks
As of March 2015, this drug has not received FDA approval for use in the treatment of cancer. It is in various clinical trials for inflammatory diseases.
Human monoclonal antibody blocks IL-8
Human monoclonal antibody blocks IL-8
Coding
This drug should NOT be coded
